ATC codes:
N05AA01
EMLc
Indication
Schizophrenia or other primary psychotic disorders
ICD11 code:
6A4Z
INN
Chlorpromazine
Medicine type
Chemical agent
List type
Core
(EML)
Complementary (EMLc)
Complementary (EMLc)
Formulations
Oral > Liquid:
25 mg per 5 mL (hydrochloride)
Oral > Solid: 100 mg (hydrochloride) ; 10 mg (hydrochloride) (EMLc) ; 25 mg (hydrochloride) (EMLc) ; 50 mg (hydrochloride) (EMLc)
Parenteral > General injections > unspecified: 25 mg per mL in 2 mL ampoule (hydrochloride)
Oral > Solid: 100 mg (hydrochloride) ; 10 mg (hydrochloride) (EMLc) ; 25 mg (hydrochloride) (EMLc) ; 50 mg (hydrochloride) (EMLc)
Parenteral > General injections > unspecified: 25 mg per mL in 2 mL ampoule (hydrochloride)
EML status history
Sex
All
Age
Also recommended for children
Therapeutic alternatives
Medicines within the same pharmacological class can be used
Therapeutic alternatives limitations
Therapeutic alternatives to be reviewed (2023)
Therapeutic alternatives limitations for EMLc
The square box does not apply for the listing of chlorpromazine on the EMLc
Patent information
Patents have expired in most jurisdictions
Read more
about patents.
Wikipedia
DrugBank
Summary of evidence and Expert Committee recommendations
Following the review of square box listings on the EML and EMLc, the Expert Committee requested the therapeutic alternatives for chlorpromazine on the EML be reviewed.